Sign in to view content

Retinal Nonperfusion and Anti-VEGF Therapy in Diabetic Retinopathy: What We Know and What We Don’t Know

Dante Joseph Pieramici, MD

Video
Published 2017

Related

Efficacy and Durability of Brolucizumab in Patients Being Transitioned From Prior Anti-VEGF Therapy
Scott D Walter, MD, MSc, FASRS
Annual Meeting Talks
2021
Fluctuations in Central Subfield Thickness Associated With Worse Visual Outcomes in Patients With Diabetic Macular Edema in Clinical Trial Setting
Matthew Starr, MD
Annual Meeting Talks
2021
Ocular Albinism
Luis Daniel Gutierrez, MD
Retina Image Bank: Images of the Week
2021

Category: Diabetic Retinopathy

See more